This was consistent with a substantial increase of CBS in MYCN-amplified NB compared to wild-type tumors (Fig. 2A), however was not the result of MYCN binding to the promoter of CBS (Fig. 2B). This evidence concerns the gene MYCN and neuroblastoma.